Electromagnetic Integrity Engineering™ for Medical Technology and Robotics

Supporting Patient Safety, Device Compliance, Reliable Automation, and Workplace Compatibility

ELEXANA | Technical references reviewed in October 2026

©2026

1. Why Electromagnetic Integrity Is Essential

Medical technology and robotics depend on the reliable interaction of sensors, processors, power electronics, communications systems, and electromechanical components. Their value rests not simply on whether they operate, but on whether their measurements, decisions, and outputs remain dependable under the conditions in which they are used.

Electromagnetic interference can compromise that dependability without causing visible damage. A system may remain powered while its measurements become unreliable, its communications are interrupted, or an intended function is disturbed. For medical devices, the FDA identifies the potential consequences as including errors or delays in diagnosis, treatment, and monitoring. [1]

At ELEXANA, we use Electromagnetic Integrity Engineering™ to describe an integrated approach to understanding and controlling electromagnetic interactions from the circuit board to the complete operating environment. It connects product design, measurement, installation, investigation, corrective engineering, and verification.

For a medical device manufacturer, this may mean resolving an EMC failure without sacrificing intended functionality. For a hospital, it may mean investigating equipment that malfunctions only in a particular room or operating condition. For a robotics developer, it may mean preserving dependable sensing and control. For an employer, it may mean evaluating the workplace for an employee who uses an implanted or body-worn medical device.

These assignments share a common objective: establishing that technology can perform its intended function reliably where it must actually operate.

2. Medical Equipment Malfunctions in Hospitals

Hospitals are not electromagnetically uniform environments. Patient-care equipment operates alongside communications infrastructure, building systems, information technology, and other medical equipment. The FDA recommends that healthcare organizations assess and manage this combined environment rather than treating each device as an isolated installation. [2]

Relevant disturbances can include radio-frequency energy, interference conducted through power or signal connections, electrostatic discharge, and electrical supply transients or interruptions. AAMI’s guidance for healthcare facilities recognizes these different phenomena and the need to manage their effects on medical equipment. [3]

Recognizing a Possible Interference Problem

An investigation may begin with intermittent shutdowns, unexplained alarms, unstable measurements, communication losses, or errors that appear only during particular procedures. Equipment may pass a maintenance check yet malfunction again after returning to its clinical location.

These symptoms do not establish that EMI is the cause. Software defects, damaged components, configuration errors, network problems, and power interruptions can produce similar observations. A defensible investigation must distinguish among these possibilities rather than assign an electromagnetic explanation merely because a failure is intermittent.

In our engineering approach, an unexplained malfunction is a system-level question. We consider the affected equipment, its interfaces, its operating history, and its environment together. The investigation should establish what the evidence supports, what remains uncertain, and what further evaluation is necessary.

The Consequence May Extend Beyond the Device

A malfunction can affect more than equipment availability. Consider an illustrative situation in which a procedure must be interrupted because a system repeatedly resets. Even when no injury occurs, the interruption may require clinical reassessment, rescheduling, additional staff involvement, and an investigation before the equipment returns to service.

The appropriate response is not to assume that every disturbance creates an emergency. It is to evaluate the affected function and its clinical significance.

This is also why EMC should involve more than the biomedical engineering department alone. The FDA recommends coordination among clinical engineering, facilities management, information systems, purchasing, and other responsible personnel. Changes to communications or building systems can be relevant to medical equipment reliability even when those changes are made outside the clinical department. [2]

3. Compliance and Reliable Hospital Operation Are Related, but Different

IEC 60601-1-2 addresses medical electrical equipment and systems in relation to electromagnetic disturbances and emissions. Its focus is basic safety and essential performance under defined conditions. It is an important foundation, but it is not a blanket guarantee that every combination of equipment, accessories, installation conditions, and nearby sources will be compatible. [4]

The engineering implication is that qualification evidence must be interpreted in context. A test report describes an evaluated configuration. An installed system must also be assessed against its intended environment, manufacturer instructions, and actual connections.

Essential Performance Must Be Defined Correctly

Essential performance concerns clinical functions whose loss or degradation beyond specified limits would create unacceptable risk. The FDA recommends device-specific, observable, and quantitative immunity acceptance criteria rather than relying on a general statement that equipment “operates as intended.” [1]

This distinction prevents two opposite errors. One is assuming that every temporary deviation necessarily represents an unacceptable safety failure. The other is assuming that a device has passed merely because it remained powered and eventually recovered.

IEC TS 60601-4-2:2024 provides additional guidance on evaluating medical equipment performance in the presence of electromagnetic disturbances. It is useful when the engineering question extends beyond identifying a safety-related failure to understanding the equipment’s broader functional behavior. [9]

Wireless Connectivity Requires Its Own Evaluation

Wireless medical systems introduce another dimension. A device can have an adequately protected electronic circuit yet experience unreliable communications because its radio link must coexist with other users of the spectrum.

The FDA’s wireless guidance addresses quality of service, coexistence, security, and EMC as related but distinct considerations. ANSI C63.27-2021 provides a framework for evaluating wireless coexistence using relevant performance indicators. [5,6]

For a connected medical system, therefore, a satisfactory emissions report does not independently demonstrate dependable delivery of clinical information. Likewise, radio-spectrum authorization is not a substitute for medical-device safety and performance evaluation.

4. When a Medical Device Cannot Pass EMC Testing

An EMC failure during development is valuable evidence, but repeated testing does not necessarily explain the underlying engineering problem.

At ELEXANA, we recommend distinguishing between identifying a failed test and understanding why the design fails. The first establishes an observed result. The second supports an appropriate correction.

A productive engineering engagement begins with the intended product, its required functions, and the conditions under which those functions must remain dependable. The objective should be to support the intended design, not to obtain an easier test result by excluding important operating modes.

Preserve Functionality While Correcting the Design

A proposed correction should be evaluated as part of the complete medical system. Changes affecting power connections, protective arrangements, patient interfaces, or system interconnections must remain consistent with applicable basic-safety requirements. EMC cannot be improved responsibly by disregarding other aspects of medical electrical safety. [7]

Our preferred approach is to investigate the demonstrated failure mechanism, develop justified changes, and verify the resulting configuration. Pre-compliance work should reduce uncertainty before formal testing, while maintaining a clear distinction between engineering development and the final conformity assessment.

Treat EMC as Part of Risk Management

ISO 14971:2019 establishes a life-cycle process for identifying hazards, evaluating risks, implementing controls, and monitoring their effectiveness. Applied to EMC, this means considering the consequences of disturbed measurements, lost communications, interrupted treatment, and other relevant functional changes. [8]

For example, the significance of a display interruption depends on what information is unavailable, how long it is unavailable, and what the user must do during that interval. The same electrical event can have different consequences in different clinical applications.

We therefore recommend integrating EMC decisions into the product’s risk-management and design records. A correction should be supported by evidence that it addresses the identified problem without introducing an unacceptable new one.

5. Medical Standards and Regulatory Expectations

There is no single standard that covers every medical device, robot, implant, wearable, and healthcare installation. Selection depends on the intended use, device characteristics, operating environment, and target market.

IEC 60601-1 and IEC 60601-1-2

IEC 60601-1 provides the general framework for basic safety and essential performance of medical electrical equipment. The consolidated Edition 3.2 incorporates the 2012 and 2020 amendments. FDA recognition includes the application of relevant U.S. national differences. [7]

IEC 60601-1-2, consolidated Edition 4.1, incorporates Amendment 1:2020 and addresses electromagnetic disturbances and emissions. FDA recognition is partial, so manufacturers must review the applicable recognition conditions rather than assume that every provision of the published standard is accepted without qualification. [4]

Applicable collateral and particular standards must also be considered. A medical system’s intended function determines the relevant requirements; the presence of electronics alone does not establish the correct standards package.

Diagnostic and Laboratory Equipment

Medical electrical equipment and laboratory equipment do not always follow the same EMC framework.

IEC 61326-2-6:2025 addresses in vitro diagnostic medical electrical equipment, including basic safety and essential performance in the presence of electromagnetic disturbances. The FDA recognizes this edition and identifies a transition period for the preceding edition. Manufacturers should verify the applicable recognition status when preparing a submission. [10]

For diagnostic equipment, EMC evaluation must consider the reliability of the result, not merely whether the instrument completes its operating sequence.

FDA EMC Guidance and Quality-System Requirements

The FDA’s June 2022 EMC guidance addresses the information used to support premarket submissions for electrically powered devices and devices with electrical or electronic functions. It is guidance, not an independent EMC certification program, and it does not replace applicable statutory or regulatory requirements. [1]

The FDA’s Quality Management System Regulation became effective on February 2, 2026. It incorporates ISO 13485:2016 by reference into the applicable medical-device quality-system requirements. EMC development, verification, changes, and complaint investigations should therefore be managed within the manufacturer’s applicable quality processes, not treated as disconnected laboratory activities. [11]

A passing EMC test is important evidence. It is not, by itself, FDA clearance or approval of the complete medical device.

6. Robotics: From Surgical Systems to Industrial Automation

Robotics requires careful electromagnetic engineering because reliable motion depends on reliable information. A robot must interpret sensor inputs, maintain communications, execute control functions, and respond appropriately when a fault occurs.

From an engineering standpoint, the relevant question is not simply whether interference can interrupt a robot. It is whether the system recognizes the disturbance, preserves necessary safety functions, and enters an appropriate condition without creating an additional hazard.

Surgical and Rehabilitation Robotics

IEC 80601-2-77:2019, including Amendment 1:2023, addresses the basic safety and essential performance of robotically assisted surgical equipment and systems. Its scope includes interaction and interface conditions, recognizing that the surgical platform must be considered as an integrated system. [12]

IEC 80601-2-78:2019, including Amendment 1:2024, addresses medical robots that physically interact with patients for rehabilitation, assessment, compensation, or alleviation related to movement functions. It does not automatically cover every powered assistive device; its scope excludes certain other equipment categories. [13]

For these systems, our engineering emphasis is on dependable sensing, controlled actuation, and appropriate responses to disturbed information. A robot should not be judged electromagnetically successful solely because its processor continues running.

Industrial Robots and Collaborative Applications

ISO 10218-1:2025 addresses industrial robot safety, while ISO 10218-2:2025 addresses industrial robot applications and robot cells. Their respective scopes distinguish the robot from its integration into a complete application. [14]

That distinction is important for EMC. Our assessment of an installed robotic system considers the assembled application, including the controller, drives, tooling, interfaces, and surrounding equipment. Evidence for individual components does not eliminate the need to evaluate integration.

For collaborative applications, the engineering significance of a disturbance depends partly on human proximity and the safety functions relied upon. Electromagnetic robustness should support those functions rather than be considered only a production-efficiency issue.

IEC 61000-6-7:2014 addresses immunity requirements for equipment intended to perform functions in safety-related systems in industrial locations. It provides an applicable technical framework where its scope and the relevant sector requirements align. An ordinary EMC pass does not independently establish complete functional-safety compliance. [17]

Mobile, Service, and Personal-Care Robots

ISO 3691-4:2023 addresses driverless industrial trucks and their systems, including applications described as automated guided vehicles and autonomous mobile robots. Its requirements include electromagnetic immunity alongside other safety considerations. [15]

ISO 13482:2014 addresses specified categories of personal-care robots in nonmedical applications. It excludes robots that are medical devices and certain other categories, demonstrating why intended use matters more than appearance or location. [16]

A delivery robot operating in a hospital does not automatically become a medical device simply because it is inside a healthcare facility. Likewise, an industrial or assistive robot does not automatically fall under a surgical-robot standard.

The same engineering discipline applies to laboratory automation, inspection platforms, and AI-enabled robotics: dependable decision-making requires dependable inputs and outputs. Software sophistication cannot substitute for evaluating the physical electronics and interfaces on which the software depends.

7. Workers with Implanted and Wearable Medical Devices

Medical technology does not remain inside hospitals. Employees may work with pacemakers, implanted defibrillators, neurostimulators, cochlear implants, insulin pumps, continuous glucose monitors, and other body-worn devices. Workplace assessment must consider the particular device and the actual work activities. [18]

Human Exposure Compliance Is Not Device Compatibility

A central distinction is that an electromagnetic exposure limit intended to protect people from direct biological effects is not necessarily a guarantee that a medical device will operate without interference.

The UK Health and Safety Executive’s guidance explicitly recognizes that workers with implanted or body-worn medical devices may need additional consideration even where exposure limits are satisfied. This is a useful engineering distinction, although UK requirements should not be represented as U.S. law. [18]

Manufacturer guidance also matters. Medtronic’s cardiac-device EMC guidance explains that some electromagnetic interactions can temporarily cause a device to deliver therapy unnecessarily or withhold needed therapy. Its recommendations vary by equipment and activity. [19]

These statements do not mean that every electrically equipped workplace is unsuitable. They mean that compatibility must be evaluated rather than inferred from a general exposure survey.

Different Devices Require Different Evidence

ISO 14117:2019 addresses EMC test protocols for specified implantable cardiac devices. ISO 14708-3:2017 addresses implantable neurostimulators. Their different scopes reinforce the need to avoid transferring assumptions from one device category to another. [20,21]

A pacemaker criterion should not be presented as proof that an implanted neurostimulator, insulin pump, or glucose monitor is compatible with the same environment. Model, configuration, intended use, and manufacturer restrictions can materially affect the assessment.

Similarly, MR Conditional labeling does not constitute unrestricted immunity to industrial electromagnetic environments. MRI safety is evaluated under specified conditions, and the FDA treats testing and labeling for the magnetic resonance environment as a distinct subject. [24]

What a Workplace Assessment Should Establish

At ELEXANA, we recommend defining the assessment around the worker’s relevant tasks and locations, the medical device information available, and the equipment operating nearby. Appropriate consultation may involve the device manufacturer, occupational health personnel, and the treating clinician.

The engineering objective is to characterize relevant conditions and identify where additional restrictions, clarification, or controls may be necessary. It is not to prove compatibility by asking a worker to approach equipment until a symptom occurs.

EN 50527-1:2016 provides a framework for assessing workers with active implanted medical devices. EN 50527-2-3:2021 provides a more specific assessment framework for certain implanted neurostimulator systems, particularly spinal cord stimulation systems. These references have defined scopes and should not be applied indiscriminately to every wearable or implant. [22,23]

Where the manufacturer has not provided usable interference criteria, the report should state that limitation. A low measurement relative to a generic benchmark does not justify an unsupported declaration of device compatibility.

Engineering Assessment Is Not Medical Clearance

Our workplace role is to evaluate the electromagnetic environment and communicate engineering findings. We do not certify the implanted device, prescribe treatment, or replace the clinician’s assessment of the worker’s medical circumstances.

We recommend that any resulting workplace plan define the conditions assessed, relevant limitations, and circumstances requiring reassessment. Changes to job duties, equipment, device models, or clinical restrictions may alter the basis of the original evaluation.

The objective should be proportionate risk management that supports informed decisions, not unnecessary exclusion from work.

8. Site Testing for Hospitals, Manufacturers, and Employers

Site testing is most useful when it is designed to answer an engineering question.

For a hospital, that question may concern an intermittent malfunction or the suitability of a location for new equipment. For a manufacturer, it may concern the environment in which a product will be deployed. For an employer, it may concern specific tasks performed by a worker using a medical device.

Measurements Must Support Decisions

Our approach begins by defining what the assessment must establish. Depending on the problem, relevant conditions may include electric or magnetic fields, radio-frequency activity, electrical supply disturbances, equipment operating states, and the characteristics of the installation.

We then relate the findings to the available equipment requirements, qualification information, manufacturer guidance, or observed functional behavior.

A general survey and a root-cause investigation are not interchangeable. A survey can characterize conditions at selected locations and times. An investigation must additionally assess whether a demonstrated relationship exists between those conditions and the malfunction.

Likewise, finding an elevated reading does not automatically establish causation, and finding low readings during one visit does not necessarily resolve an intermittent problem.

Testing Must Not Compromise Clinical or Operational Safety

We recommend planning hospital investigations with the responsible clinical and engineering personnel, using authorized procedures and appropriate controls. Diagnostic work should not involve improvised interference exposure to patients or uncontrolled disturbance of active clinical systems.

Corrections also require discipline. Protective arrangements should not be bypassed to make a symptom disappear. A successful engineering outcome must preserve required safety functions and be supported by appropriate verification.

Compatibility Requires Ongoing Attention

The FDA recommends considering EMC during healthcare-facility site selection, design, construction, installation, and equipment management. [2]

Our practical recommendation is to retain a clear record of assessed conditions and significant changes. This allows future engineers to determine whether a new equipment configuration, wireless installation, or facility modification remains consistent with the original assessment.

9. Why ELEXANA Is a Strong Choice

ELEXANA brings together two perspectives that are particularly valuable in medical technology and robotics: understanding the electromagnetic behavior of the product and understanding the environment in which it operates.

Our work includes product-level EMC engineering and redesign as well as investigations of equipment malfunctions within facilities. This allows us to examine a problem without assuming that the cause must reside entirely inside the affected device or entirely within the building. [25,26]

Demonstrated Medical Robotics Experience

In a published surgical-robotics engagement, a manufacturer’s system was unable to pass EMC testing in its intended configuration. Five functions had been disabled in an effort to address the problem.

Working with the manufacturer, ELEXANA performed engineering redesign that included two printed circuit boards and aspects of system integration. The five functions were restored, and the redesigned robotic system passed EMC testing in its restored functional configuration. [25]

The significance is not simply that a passing result was obtained. The engineering objective was to preserve the intended product functionality while resolving the electromagnetic problem.

Experience with Difficult Facility Malfunctions

In a separate healthcare engagement, ELEXANA investigated intermittent shutdowns affecting a mission-critical medical system after a facility electrical event. The investigation considered the equipment and its surrounding infrastructure rather than limiting the assessment to routine device troubleshooting. [26]

These are different assignments requiring different evidence. Our value is in recognizing that distinction and developing an appropriate engineering scope.

Independent Recommendations

ELEXANA does not sell mitigation products or receive mitigation commissions. Our recommendations are therefore not tied to selling a predetermined filter, shielding product, or other remedy. [27]

We focus on establishing a defensible understanding of the problem, communicating the limitations of the evidence, and developing technically justified recommendations.

For manufacturers, that can mean support from investigation through corrective design and verification. For hospitals, it can mean an independent assessment of an unresolved malfunction. For employers, it can mean workplace measurements and engineering interpretation coordinated with device-manufacturer and clinical guidance.

10. Engineering Confidence into Essential Technologies

Medical devices and robots must do more than function in favorable conditions. They must perform dependably in the environments for which they are intended, with appropriate responses when disturbances or faults occur.

Electromagnetic Integrity Engineering™ connects that requirement to product design, conformity assessment, installation, investigation, and continued operation.

For ELEXANA, the objective is not merely to produce measurements or a test result. It is to help clients understand difficult electromagnetic problems and make informed decisions about the systems on which patients, clinicians, workers, and operations depend.

ELEXANA provides independent electromagnetic engineering consulting for medical technology, robotics, healthcare facilities, and workplaces involving implanted or wearable medical devices. Contact us to discuss a product-development challenge, an unresolved malfunction, or a site-specific assessment.

This article provides general engineering information. Applicable requirements and conclusions must be established for the particular device, intended use, installation, and jurisdiction. Workplace engineering assessments do not replace manufacturer instructions or clinical judgment.

References

[1] U.S. Food and Drug Administration, Electromagnetic Compatibility (EMC) of Medical Devices: Guidance for Industry and Food and Drug Administration Staff, June 6, 2022. U.S. Food and Drug Administration

[2] U.S. Food and Drug Administration, Center for Devices and Radiological Health, FDA/CDRH Recommendations for EMC/EMI in Healthcare Facilities. Accessed October 2026. U.S. Food and Drug Administration

[3] Association for the Advancement of Medical Instrumentation, Guidance on Electromagnetic Compatibility of Medical Devices in Healthcare Facilities, AAMI TIR18:2010, 2010. my.aami.org

[4] International Electrotechnical Commission, Medical Electrical Equipment, Part 1-2: General Requirements for Basic Safety and Essential Performance, Collateral Standard: Electromagnetic Disturbances, Requirements and Tests, IEC 60601-1-2:2014+AMD1:2020, Edition 4.1, 2020. See also U.S. FDA recognition no. 19-36 and its conditions of recognition. IEC Webstore

[5] U.S. Food and Drug Administration, Radio Frequency Wireless Technology in Medical Devices: Guidance for Industry and FDA Staff, August 2013. U.S. Food and Drug Administration

[6] IEEE, American National Standard for Evaluation of Wireless Coexistence, ANSI C63.27-2021, 2021. U.S. FDA recognition no. 19-48. Access Data FDA

[7] International Electrotechnical Commission, Medical Electrical Equipment, Part 1: General Requirements for Basic Safety and Essential Performance, IEC 60601-1:2005+AMD1:2012+AMD2:2020, Edition 3.2, 2020. See also U.S. FDA recognition no. 19-49, including applicable U.S. national differences. Access Data FDA

[8] International Organization for Standardization, Medical Devices: Application of Risk Management to Medical Devices, ISO 14971:2019, third edition, 2019. ISO

[9] International Electrotechnical Commission, Medical Electrical Equipment, Part 4-2: Guidance and Interpretation, Electromagnetic Immunity: Performance of Medical Electrical Equipment and Medical Electrical Systems, IEC TS 60601-4-2:2024, 2024. IEC Webstore

[10] International Electrotechnical Commission, Electrical Equipment for Measurement, Control and Laboratory Use: EMC Requirements, Part 2-6: Particular Requirements, In Vitro Diagnostic Medical Electrical Equipment, IEC 61326-2-6:2025, fourth edition, 2025. See also U.S. FDA recognition no. 19-57 and its transition provisions. IEC Webstore

[11] U.S. Food and Drug Administration, Quality Management System Regulation (QMSR), 21 CFR Part 820, effective February 2, 2026; incorporating ISO 13485:2016 by reference. U.S. Food and Drug Administration

[12] International Electrotechnical Commission, Medical Electrical Equipment, Part 2-77: Particular Requirements for the Basic Safety and Essential Performance of Robotically Assisted Surgical Equipment, IEC 80601-2-77:2019+AMD1:2023, Edition 1.1, 2023. IEC Webstore

[13] International Electrotechnical Commission, Medical Electrical Equipment, Part 2-78: Particular Requirements for Basic Safety and Essential Performance of Medical Robots for Rehabilitation, Assessment, Compensation or Alleviation, IEC 80601-2-78:2019+AMD1:2024, Edition 1.1, 2024. IEC Webstore

[14] International Organization for Standardization, Robotics: Safety Requirements, Part 1: Industrial Robots, ISO 10218-1:2025; and Part 2: Industrial Robot Applications and Robot Cells, ISO 10218-2:2025, 2025. ISO

[15] International Organization for Standardization, Industrial Trucks: Safety Requirements and Verification, Part 4: Driverless Industrial Trucks and Their Systems, ISO 3691-4:2023, second edition, 2023. ISO

[16] International Organization for Standardization, Robots and Robotic Devices: Safety Requirements for Personal Care Robots, ISO 13482:2014, 2014. ISO

[17] International Electrotechnical Commission, Electromagnetic Compatibility, Part 6-7: Generic Standards, Immunity Requirements for Equipment Intended to Perform Functions in a Safety-Related System in Industrial Locations, IEC 61000-6-7:2014, 2014. IEC Webstore

[18] Health and Safety Executive, Electromagnetic Fields at Work: A Guide to the Control of Electromagnetic Fields at Work Regulations 2016, HSG281, first edition, 2016, particularly pp. 17–18. HSE

[19] Medtronic, Electromagnetic Compatibility Guide: Patient Services for Implantable Cardiac Devices. Accessed October 2026. Medtronic

[20] International Organization for Standardization, Active Implantable Medical Devices: Electromagnetic Compatibility, EMC Test Protocols for Implantable Cardiac Pacemakers, Implantable Cardioverter Defibrillators and Cardiac Resynchronization Devices, ISO 14117:2019, second edition, 2019. ISO

[21] International Organization for Standardization, Implants for Surgery: Active Implantable Medical Devices, Part 3: Implantable Neurostimulators, ISO 14708-3:2017, second edition, 2017. ISO

[22] British Standards Institution, Procedure for the Assessment of the Exposure to Electromagnetic Fields of Workers Bearing Active Implantable Medical Devices, Part 1: General, BS EN 50527-1:2016, 2016. BSI Knowledge

[23] British Standards Institution, Procedure for the Assessment of the Exposure to Electromagnetic Fields of Workers Bearing Active Implantable Medical Devices, Part 2-3: Specific Assessment for Workers with Implantable Neurostimulators, BS EN 50527-2-3:2021, 2021. BSI Knowledge

[24] U.S. Food and Drug Administration, Testing and Labeling Medical Devices for Safety in the Magnetic Resonance Environment: Guidance for Industry and Food and Drug Administration Staff, October 10, 2023. U.S. Food and Drug Administration

[25] ELEXANA, Surgical Robotics: From EMC Failure to Full-Function Compliance, published case study. Accessed October 2026. ELEXANA USA

[26] ELEXANA, Intermittent Shutdowns in Mission-Critical Medical Equipment, published case study. Accessed October 2026. ELEXANA USA

[27] ELEXANA, No Conflicts of Interest Policy. Accessed October 2026. ELEXANA USA